Skip to main content
Premium Trial:

Request an Annual Quote

Alnylam siRNA Upheld by German Patent Office

Premium

Alnylam Pharmaceuticals said last week that the German patent office has upheld the company's Kreutzer-Limmer patent in oral proceedings held before the office's opposition board.

The patent, DE 10066235, was granted in January 2008, and covers methods, uses, and medicaments of siRNAs, with a length between 15 and 49 nucleotides, expressed through a vector, according to Alnylam.

Additionally, the patent office rejected a request by Silence Therapeutics, Pfizer, and Sanofi-Aventis, which has opposed the patent, to revoke the intellectual property, the company said.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.